Details for Patent: 9,636,407

Which drugs does patent 9,636,407 protect, and when does it expire?

Patent 9,636,407 protects CASPOFUNGIN ACETATE and is included in one NDA.

This patent has fourteen patent family members in fourteen countries.

Summary for Patent: 9,636,407

Patent landscape, scope, and claims:

Title:	Caspofungin acetate formulations
Abstract:	A caspofungin composition includes caspofungin acetate and at least one amino acid, where the composition is a solid. The solid composition may be made by forming a liquid mixture including a solvent, caspofungin acetate and the amino acid(s), and lyophilizing the liquid mixture.
Inventor(s):	Jiang; John Zhiqiang (Chicago, IL), Usayapant; Arunya (Mundelein, IL), Bowman; David (Mattawan, MI), Kwok; Keith (Long Grove, IL), Peterson; Joel (New Lenox, IL)
Assignee:	FRESENIUS KABI USA, LLC (Lake Zurich, IL)
Application Number:	13/724,266
Patent Claim Types: see list of patent claims	Use; Composition;

Drugs Protected by US Patent 9,636,407

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Fresenius Kabi Usa	CASPOFUNGIN ACETATE	caspofungin acetate	POWDER;INTRAVENOUS	206110-001	Dec 30, 2016	AP	RX	No	No			Y
Fresenius Kabi Usa	CASPOFUNGIN ACETATE	caspofungin acetate	POWDER;INTRAVENOUS	206110-002	Dec 30, 2016	AP	RX	No	No			Y

International Family Members for US Patent 9,636,407

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Canada	2888625
Cyprus	1120016
Denmark	2922530